RGNX·75901B107·US·Common Stock·Healthcare - Biotechnology-13D/G
RGNX (REGENXBIO INC) is held by 100 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($48.5M), JPMORGAN CHASE & CO ($27.1M), STATE STREET CORP ($22.9M). Net institutional sentiment: Mixed.
Showing 1-20 of 111
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer